Utah Medical Products, Inc. (UTMD) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
04M8M11M15M19M22M26M30MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Margin (%)

Gross MarginOperating MarginNet Income Margin
0255075100125150175200Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Operating Expenses

Research And Development ExpensesSelling General And Administrative ExpensesOther Expenses
01M2M3M4M6M7M8M9MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

EBITDA

EBITDA
0750K2M2M3M4M4M5M6MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

EPS

EPSEPS Diluted
001122233Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Revenue Variation (%)

Revenue Variation
-10-8-6-4-21357Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Income Variation (%)

Gross Profit VariationOperating Income Variation
02581012151820Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Revenue YoY Variation (%)

Revenue YoY Variation
-30-26-22-18-14-11-7-31Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Income YoY Variation (%)

Price-to-Earning Ratio

P/E Ratio
048111519222630Q4 2024Q1 2025Q2 2025Q3 2025

Income Breakdown

Operating IncomeTotal Other Income Expenses NetNet Income
01M2M3M4M5M6M7M8MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Per Share Metrics

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
012234456Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Expense Ratios

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
000001111Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
💰 Cash Flow Statement

Operating Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
02M5M8M10M12M15M18M20MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Free Cash Flow

Cash At End Of Period
012M25M38M50M62M75M88M100MQ4 2024Q1 2025Q2 2025Q3 2025

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
0750K2M2M3M4M4M5M6MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025
🏦 Balance Sheet
📈 Key Metrics